Background: Lymphnode metastases for well-differentiated thyroid cance
r are associated with high recurrence rates. Surgical options consist
of blind nodal sampling, ''berry-picking'' procedures, and modified ra
dical neck dissections. Sentinel lymph node dissection (SLND) has been
described by our institution for melanoma and breast cancer. We have
investigated the feasibility of SLND for thyroid cancer. Design: From
August 1994 to October 1996 we investigated the technique of intraoper
ative lymphatic mapping and SLND in 17 patients undergoing surgical ma
nagement of a suspicious thyroid nodule not accompanied by palpable ce
rvical adenopathy. Setting: Patients were referred from endocrinologis
ts in community and academic practices. Procedures were performed in a
community hospital. Patients: There were 14 women and 3 men, ranging
in age from 22 to 69 years (median, 48 years). Interventions: At surge
ry, we exposed the thyroid lobe and used a tuberculin syringe to injec
t 0.1 to 0.8 mt of 1.0% isosulfan blue dye (mean, 0.5 mt) directly int
o the thyroid mass. Within seconds the blue dye passed along the lymph
atics to the sentinel lymph node, which was then excised. Nodes were e
xamined by routine processing and keratin immunohistochemical analysis
to detect micrometastasis. Main Outcome Measures: The feasibility of
lymphatic mapping in determining primary drainage of suspicious thyroi
d nodules. Results: Lymphatic mapping and SLND was followed by total t
hyroidectomy, except in 1 patient who underwent lobectomy for benign d
isease. Of the 17 nodules, 12 were ultimately diagnosed as thyroid car
cinoma, 3 were follicular adenomas, and 2 were colloid nodules. Tumor
sizes ranged from 0.8 to 4.0 cm. Lymphatic mapping was unsuccessful in
2 patients, whose lymphatics mapped to the retrosternum. All of the s
entinel lymph nodes were paratracheal except in 2 women who also had j
ugular nodes that stained blue. Five (42%) of the 12 tumor nodules wer
e associated with positive sentinel lymph nodes. Central neck dissecti
ons were performed in 5 patients; in 2 instances (17%), the sentinel n
ode was the only tumor-bearing lymph node. Conclusions: This is the fi
rst report of SLND for thyroid carcinoma. Our preliminary findings ind
icate that SLND can detect nonpalpable nodal metastasis with the same
ease as in melanoma and breast cancer. The clinical significance of th
is technique in thyroid cancer remains to be determined.